Transmedics Group Inc (TMDX)

Finanzdaten der Transmedics Group Inc-Aktie (TMDX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	19.31% 96.85	81.17	66.43	52.47	41.55
Cost Of Revenue	10.94% 36.89	33.25	25.77	15.72	12.79
Gross Profit	25.12% 59.96	47.92	40.66	36.74	28.77
Operating Expenses	4.90% 47.54	45.32	69.00	37.65	30.86
Interest Income/Expense	0.19% 3.598	3.605	3.59	2.505	1.091
Benefits Costs and Expenses	9.24% 84.46	77.31	93.36	53.45	44.18
Costs And Expenses	9.24% 84.46	77.31	93.36	53.45	44.18
Operating Income/Loss	377.18% 12.42	2.603	-28.34	-0.906	-2.089
Nonoperating Income/Loss	102.22% -0.028	1.26	1.406	-0.074	-0.536
Income/Loss From Continuing Operations Before Tax	220.81% 12.39	3.863	-26.93	-0.98	-2.625
Income Tax Expense/Benefit, Current	216.67% 0.196	-0.168	-1.507	0.021	0.011
Income Tax Expense/Benefit	85.10% 0.196	1.315	-1.507	0.021	0.011
Income/Loss From Continuing Operations After Tax	378.69% 12.20	2.548	-25.42	-1.001	-2.636
Net Income/Loss	202.58% 12.20	4.031	-25.42	-1.001	-2.636
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	76,353% 32.76	0.0429	32.61	32.55	32.26
Diluted Average Shares	80,831% 34.68	0.0429	32.61	32.55	32.26
Basic Earnings Per Share	208.33% 0.37	0.12	-0.78	-0.03	-0.08
Diluted Earnings Per Share	191.67% 0.35	0.12	-0.78	-0.03	-0.08
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-